Preventive effect of Rikkunshito, a traditional Japanese medicine, on chemotherapy-induced nausea and vomiting with cisplatin: Case series

Keyphrases

• Traditional Japanese Medicine 100%
• Cisplatin 100%
• Preventive Effect 100%
• Chemotherapy-induced Nausea 100%
• Rikkunshito 100%
• Second Course 40%
• Gastric Cancer 20%
• Esophageal Cancer 20%
• Low-dose Cisplatin 20%
• Cisplatin-based Chemotherapy 20%
• Anorexia 10%
• Orally Administered 10%
• No Significant Difference 10%
• Complete Response 10%
• Chemotherapy 10%
• Corticosteroids 10%
• Kampo Medicine 10%
• Common Terminology Criteria for Adverse Events (CTCAE) 10%
• Anticancer Drugs 10%
• Patient Selection 10%
• Cisplatin-induced 10%
• Chemotherapy Regimen 10%
• 5-fluorouracil (5-FU) 10%
• Rescue Medication 10%
• 5-hydroxytryptamine-3 Receptor Antagonist 10%
• Neurokinin-1 Receptor Antagonist 10%
• Supportive Therapy 10%
• Emesis 10%

Medicine and Dentistry

• Medicine 100%
• Cisplatin 100%
• Chemotherapy-Induced Nausea and Vomiting 100%
• Rikkunshito 100%
• Chemotherapy 42%
• Drug Therapy 28%
• Esophageal Cancer 28%
• Drug Megadose 28%
• Abdominal Cancer 28%
• Anorexia 14%
• Adverse Event 14%
• Fluorouracil 14%
• Kampo 14%
• Chemotherapy Regimens 14%
• Neurokinin 1 Receptor Antagonist 14%
• 5-HT3 Antagonist 14%
• Vomiting 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Cisplatin 100%
• Chemotherapy Induced Nausea and Vomiting 100%
• Rikkunshito 100%
• Chemotherapy 42%
• Abdominal Cancer 28%
• Esophagus Cancer 28%
• Kampo Medicine (Drug) 14%
• Adverse Event 14%
• Fluorouracil 14%
• Anorexia 14%
• Chemotherapy Regimens 14%
• Neurokinin 1 Receptor Antagonist 14%
• Serotonin 3 Antagonist 14%
• Vomiting 14%